Newland Pharmaceutical Co., Ltd.

SZSE:301277 Stock Report

Market Cap: CN¥4.1b

Newland Pharmaceutical Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Luwei Zhang

Chief executive officer

CN¥482.4k

Total compensation

CEO salary percentagen/a
CEO tenure15.6yrs
CEO ownership0.6%
Management average tenureno data
Board average tenure5.7yrs

Recent management updates

Recent updates

Newland Pharmaceutical (SZSE:301277) Will Pay A Smaller Dividend Than Last Year

May 03
Newland Pharmaceutical (SZSE:301277) Will Pay A Smaller Dividend Than Last Year

CEO

Luwei Zhang (53 yo)

15.6yrs

Tenure

CN¥482,400

Compensation

Mr. Luwei Zhang is General Manager & Director of Newland Pharmaceutical Co., Ltd. (formerly known as Henan Newland Pharmaceutical Co., Ltd.) since April 18, 2009.

Board Members

NamePositionTenureCompensationOwnership
Luwei Zhang
GM & Director15.6yrsCN¥482.40k0.55%
CN¥ 22.6m
Chao Liu
Deputy GM & Director5.7yrsCN¥401.80kno data
Binggang Zhang
Director15.6yrsno data0.55%
CN¥ 22.6m
Changchun Liu
Supervisor4.1yrsno data0.41%
CN¥ 16.9m
Heping Xu
Supervisory Board Chairman9.3yrsno data0.55%
CN¥ 22.6m
Wanmin Liu
Vice Chairman15.6yrsCN¥438.90k0.41%
CN¥ 16.9m
Jianzhong Xie
Chairman of the Board15.6yrsCN¥567.30k63.21%
CN¥ 2.6b
Jingbao Wang
Independent Director4.1yrsCN¥60.00kno data
Faliang Jia
Independent Director3.8yrsCN¥60.00kno data
Yu Ke
Independent Director3.7yrsCN¥60.00kno data
Hongmin Liu
Non-Independent Directorless than a yearCN¥600.00kno data

5.7yrs

Average Tenure

58.5yo

Average Age

Experienced Board: 301277's board of directors are considered experienced (5.7 years average tenure).